Table 3 Correlation of cell survival with Clinical and Pathological Factors

Characteristics

%

P

n

%

n

%

P

All Patients

32

41.0

46

59.0

Age at diagnosis, years

.877

1.000

  ≤50

51.44

18

41.9

25

58.1

  >50

52.61

14

40.0

21

60.0

Mean

.817

Range

Tumor stage

.181

.603

  cT1/T2

49.40

24

42.9

32

57.1

  cT3/4

60.66

7

33.3

14

66.7

Nodal status

.813

1.000

  cN+

50.41

17

40.5

25

59.5

  cN-

52.20

15

42.9

20

57.1

Grading

.339

.486

  G1/2

55.34

15

36.6

26

63.4

  G3

48.09

16

45.7

19

54.3

  Not documented

-

-

Histologic type

.569

.439

  Ductal invasive/other

51.25

30

42.9

40

57.1

  Lobular invasive

58.29

2

25.0

6

75.0

HR status

.038

.042

  ER+/PR+

62.49

10

25.6

29

74.4

  ER+/PR-/Unknown

36.10

7

70.0

3

30.0

  ER-/unknown/PR+

47.82

1

50.0

1

50.0

  ER-/PR-

43.03

12

50.0

12

50.0

HER2 status

.000

<.0001

  Negative

58.34

17

28.8

42

71.2

  Positive

30.70

13

81.3

3

18.8